Amanda Reyes, OD
Optometrist · Miami, FLNPI 1700445772
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,816 of the $2,366 with a category attached, or 76.7%. It is spread thinly across 11 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $825 and has fallen 72.6% since, to $226 in 2025.
Across 34 payments — averaging $69.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$512
- The Walman Optical Company$350
- Optos, Inc.$314
- Bausch & Lomb Americas Inc.$280
- Bausch & Lomb, A Division Of Bausch Health US, LLC$249
- Coopervision Inc.$169
- plus $493 from 5 others
Across 6 payments — averaging $2992.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$18K
What the payments were for
- Food & beverage$1,81677%
- Gifts$35015%
- Entertainment$2018%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 17 | $512 |
| The Walman Optical Company | 1 | $350 |
| Optos, Inc. | 3 | $314 |
| Bausch & Lomb Americas Inc. | 2 | $280 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $249 |
| Coopervision Inc. | 3 | $169 |
| Sun Pharmaceutical Industries Inc. | 1 | $118 |
| Maculogix, Inc. | 1 | $115 |
| Aerie Pharmaceuticals, Inc. | 1 | $113 |
| Rxsight Inc | 2 | $83 |
| Topcon Healthcare, Inc. | 1 | $64 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,366 in reported general payments places this provider in the 75th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 16 | $11,533 |
| Azelastine Hcl | 19 | $447 |
| Latanoprost | 34 | $150 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Miami
- Mark DunbarMiami$236K
- Elise KramerMiami$168K
- Diana ShechtmanMiami$78K
- Angelica CifuentesMiami$68K
- Kristie DraskovicMiami$36K
- Arnaldo CarmouzeMiami$25K
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$553K
- Nora CothranLargo$505K
- Michael SluskyNorth Port$384K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.